CYP2D6 polymorphisms and their influence on risperidone treatment.

Pharmgenomics Pers Med · 2016 · PMC5138038 · PMID 27942231

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

90 However, one study showed a trend of the association between CYP2D6 PM phenotype and the presence of tardive dyskinesia (TD).

also in 53,322 other papers

a borderline significant trendno p-value reported

Although several studies showed no significant difference of EPS among CYP2D6 variation, some of them showed a borderline significant trend.

also in 231 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.